Markets
Canaccord Initiates Twist Bioscience With Buy Rating: What Traders Need to Know
Canaccord Genuity has initiated coverage of Twist Bioscience with a Buy rating, adding institutional credibility to a synthetic biology name that has quietly rebuilt momentum in 2026. Here is what the initiation signals and how traders should position around it.